206 related articles for article (PubMed ID: 18406873)
1. Characterization of 9p21 copy number alterations in human melanoma by fluorescence in situ hybridization.
Rákosy Z; Vízkeleti L; Ecsedi S; Bégány A; Emri G; Adány R; Balázs M
Cancer Genet Cytogenet; 2008 Apr; 182(2):116-21. PubMed ID: 18406873
[TBL] [Abstract][Full Text] [Related]
2. Molecular alterations at chromosome 9p21 in melanocytic naevi and melanoma.
Sini MC; Manca A; Cossu A; Budroni M; Botti G; Ascierto PA; Cremona F; Muggiano A; D'Atri S; Casula M; Baldinu P; Palomba G; Lissia A; Tanda F; Palmieri G
Br J Dermatol; 2008 Feb; 158(2):243-50. PubMed ID: 18028495
[TBL] [Abstract][Full Text] [Related]
3. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.
Gammon B; Beilfuss B; Guitart J; Gerami P
Am J Surg Pathol; 2012 Jan; 36(1):81-8. PubMed ID: 21989344
[TBL] [Abstract][Full Text] [Related]
4. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
5. CDKN2A mutation and deletion status in thin and thick primary melanoma.
Cachia AR; Indsto JO; McLaren KM; Mann GJ; Arends MJ
Clin Cancer Res; 2000 Sep; 6(9):3511-5. PubMed ID: 10999737
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal localization of phospholipase A2 activating protein, an Ets2 target gene, to 9p21.
Beatty BG; Qi S; Pienkowska M; Herbrick JA; Scheidl T; Zhang ZM; Kola I; Scherer SW; Seth A
Genomics; 1999 Dec; 62(3):529-32. PubMed ID: 10644453
[TBL] [Abstract][Full Text] [Related]
7. Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway.
Berner JM; Sørlie T; Mertens F; Henriksen J; Saeter G; Mandahl N; Brøgger A; Myklebost O; Lothe RA
Genes Chromosomes Cancer; 1999 Oct; 26(2):151-60. PubMed ID: 10469453
[TBL] [Abstract][Full Text] [Related]
8. Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases. The Melanoma Cooperative Group.
Palmieri G; Cossu A; Ascierto PA; Botti G; Strazzullo M; Lissia A; Colombino M; Casula M; Floris C; Tanda F; Pirastu M; Castello G;
Br J Cancer; 2000 Dec; 83(12):1707-14. PubMed ID: 11104570
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of a t(9;12)(p21;q13) balanced chromosome translocation in combination with integrative genomics analysis identifies C9orf14 as a candidate tumor-suppressor.
Pujana MA; Ruiz A; Badenas C; Puig-Butille JA; Nadal M; Stark M; Gómez L; Valls J; Solé X; Hernández P; Cerrato C; Madrigal I; de Cid R; Aguilar H; Capellá G; Cal S; James MR; Walker GJ; Malvehy J; Milà M; Hayward NK; Estivill X; Puig S
Genes Chromosomes Cancer; 2007 Feb; 46(2):155-62. PubMed ID: 17099875
[TBL] [Abstract][Full Text] [Related]
10. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.
Bertin R; Acquaviva C; Mirebeau D; Guidal-Giroux C; Vilmer E; Cavé H
Genes Chromosomes Cancer; 2003 May; 37(1):44-57. PubMed ID: 12661005
[TBL] [Abstract][Full Text] [Related]
11. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder.
Krüger S; Mess F; Böhle A; Feller AC
Int J Oncol; 2003 Jul; 23(1):41-8. PubMed ID: 12792774
[TBL] [Abstract][Full Text] [Related]
12. Extra copies of c-myc are more pronounced in nodular melanomas than in superficial spreading melanomas as revealed by fluorescence in situ hybridisation.
Treszl A; Adány R; Rákosy Z; Kardos L; Bégány A; Gilde K; Balázs M
Cytometry B Clin Cytom; 2004 Jul; 60(1):37-46. PubMed ID: 15221868
[TBL] [Abstract][Full Text] [Related]
13. Retention of polysomy at 9p23-24 during karyotypic evolution in human breast cancer cell line COLO 824.
Savelyeva L; Claas A; An H; Weber RG; Lichter P; Schwab M
Genes Chromosomes Cancer; 1999 Jan; 24(1):87-93. PubMed ID: 9892114
[TBL] [Abstract][Full Text] [Related]
14. A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family.
Knappskog S; Geisler J; Arnesen T; Lillehaug JR; Lønning PE
Genes Chromosomes Cancer; 2006 Dec; 45(12):1155-63. PubMed ID: 17001621
[TBL] [Abstract][Full Text] [Related]
15. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.
Kraehn GM; Utikal J; Udart M; Greulich KM; Bezold G; Kaskel P; Leiter U; Peter RU
Br J Cancer; 2001 Jan; 84(1):72-9. PubMed ID: 11139316
[TBL] [Abstract][Full Text] [Related]
16. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer.
Hazra A; Grossman HB; Zhu Y; Luo S; Spitz MR; Wu X
Genes Chromosomes Cancer; 2004 Dec; 41(4):330-8. PubMed ID: 15390186
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas.
Weber RG; Hoischen A; Ehrler M; Zipper P; Kaulich K; Blaschke B; Becker AJ; Weber-Mangal S; Jauch A; Radlwimmer B; Schramm J; Wiestler OD; Lichter P; Reifenberger G
Oncogene; 2007 Feb; 26(7):1088-97. PubMed ID: 16909113
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the molecular genetics of malignant melanoma.
Haluska FG; Housman DE
Cancer Surv; 1995; 25():277-92. PubMed ID: 8718523
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma.
Holland EA; Beaton SC; Edwards BG; Kefford RF; Mann GJ
Oncogene; 1994 May; 9(5):1361-5. PubMed ID: 8152796
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.
Obermann EC; Meyer S; Hellge D; Zaak D; Filbeck T; Stoehr R; Hofstaedter F; Hartmann A; Knuechel R
Oncol Rep; 2004 Apr; 11(4):745-51. PubMed ID: 15010867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]